Cardiomegaly

Jump to navigation Jump to search

Template:DiseaseDisorder infobox

Cardiomegaly Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Cardiomegaly from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

MRI

CT

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cardiomegaly On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cardiomegaly

CDC on Cardiomegaly

Cardiomegaly in the news

Blogs on Cardiomegaly

Directions to Hospitals Treating Cardiomegaly

Risk calculators and risk factors for Cardiomegaly

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor in Chief: Cafer Zorkun, M.D., Ph.D. [2]

Overview

Pathophysiology

Epidemiology and demographics

Risk factors

Screening

Natural History, Complications & Prognosis

Causes

Differential diagnosis of cardiomegaly

Diagnosis

History and Symptoms | Physical examination | Lab tests | Electrocardiogram | Chest x ray | MRI | CT | Echocardiogpraphy or ultrasound | Other diagnostic studies | Pathological findings

Other Diagnostic Studies

Pathological Findings

Image courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology

Right ventricular enlargement due to a patent ductus arteriosus in a patient with hyaline membrane disease


Treatment

Pharmacotherapy

Acute Pharmacotherapies

Chronic Pharmacotherapies

A combination of diuretics and angiotensin converting enzyme (ACE) inhibition is currently the standard of care. Digoxin may reduce the frequency of rehospitalization, but does not improve mortality.

Surgery and Device Based Therapy

Transplantation

Future or Investigational Therapies

Mechanical strategies currently under investigation include:

  1. Development of devices to reduce the size of the heart
  2. Development of a device to exclude that portion of the apex where clots may form.

Pathological Findings

Image courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology

Biventricular Hypertrophy


Biventricular Hypertrophy


Gross excellent example of concentric left ventricular hypertrophy


Left Ventricular Hypertrophy: Gross natural color anterior view intact heart showing disproportionate size of left ventricle by its inferior extent much below the right ventricle apex (quite good example)


Myocardial Infarct: Gross natural color apical section showing large left ventricle infarct and right ventricular hypertrophy


Right ventricular hypertrophy


References


Template:WikiDoc Sources